• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pyxis Oncology, Inc. - Common Stock (NQ:PYXS)

1.760 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 781
Open 1.760
Bid (Size) 1.760 (500)
Ask (Size) 1.820 (300)
Prev. Close 1.760
Today's Range 1.760 - 1.760
52wk Range 1.030 - 5.550
Shares Outstanding 38,245,287
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Pyxis Oncology Announces Closing of Up to $282.6 Million Public Offering
October 02, 2026
From Pyxis Oncology
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session. ↗
September 30, 2026
Via Chartmill

Performance

52-Week Range 68.3% below 52-week high
1.760
1.0352W Low 5.5552W High
1 Week 11.9% below 1-week high
1.661W Low 2.001W High

Pyxis Oncology, Inc. - Common Stock (PYXS) traded between $1.03 and $5.55 over the past 52 weeks and last traded at $1.76, 68.3% below its 52-week high. Over the past week it ranged between $1.66 and $2.00.

Past 12 Months
-4.9%
-44.8%
-21.8%
+3.5%
+53.0%
-50.8%
1W -$0.09
1M -$1.43
3M -$0.49
6M +$0.06
YTD +$0.61
1Y -$1.82

PYXS was -50.8% over the past year, +3.5% over six months, +53.0% year to date, -4.9% in the last week.

12 Months vs Market
PYXS
-50.8%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months PYXS returned -50.8% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.00× 3-mo avg
Today 781 3-mo avg 1.3M
1W
986.2K
1M
1.3M
3M
1.3M
6M
1.1M
YTD
914.0K
1Y
966.4K

PYXS most recently traded 781 shares against a 3-month average daily volume of 1.3M.

More News

Read More
Which stocks are gapping on Wednesday? ↗
September 30, 2026
Via Chartmill
Wednesday's pre-market session: top gainers and losers ↗
September 30, 2026
Via Chartmill
News headline image
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
September 30, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Announces Proposed Public Offering
September 29, 2026
From Pyxis Oncology
Via GlobeNewswire
Top movers in Wednesday's pre-market session ↗
September 09, 2026
Via Chartmill
News headline image
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
September 09, 2026
From Pyxis Oncology
Via GlobeNewswire
Wondering what's happening in today's after-hours session? ↗
September 08, 2026
Via Chartmill
News headline image
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
September 08, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
September 08, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Upcoming Investor Conferences
September 01, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
August 13, 2026
From Pyxis Oncology
Via GlobeNewswire
What's going on in today's session ↗
August 11, 2026
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
July 07, 2026
Via Chartmill
Top stock movements in today's session. ↗
July 07, 2026
Via Chartmill
News headline image
Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones
June 30, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
May 14, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Upcoming Investor Conferences
May 13, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
May 07, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 23, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
February 03, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
January 12, 2026
From Equity Insider
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
January 09, 2026
Via Chartmill
News headline image
Unusual volume stocks in Tuesday's session ↗
December 23, 2025
Via Chartmill

Frequently Asked Questions

Is Pyxis Oncology, Inc. - Common Stock publicly traded?
Yes, Pyxis Oncology, Inc. - Common Stock is publicly traded.
What exchange does Pyxis Oncology, Inc. - Common Stock trade on?
Pyxis Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pyxis Oncology, Inc. - Common Stock?
The ticker symbol for Pyxis Oncology, Inc. - Common Stock is PYXS on the Nasdaq Stock Market
What is the current price of Pyxis Oncology, Inc. - Common Stock?
The current price of Pyxis Oncology, Inc. - Common Stock is 1.760
When was Pyxis Oncology, Inc. - Common Stock last traded?
The last trade of Pyxis Oncology, Inc. - Common Stock was at 10/19/26 04:00 PM ET
What is the market capitalization of Pyxis Oncology, Inc. - Common Stock?
The market capitalization of Pyxis Oncology, Inc. - Common Stock is 67.31M
How many shares of Pyxis Oncology, Inc. - Common Stock are outstanding?
Pyxis Oncology, Inc. - Common Stock has 67M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap